Coagulation Factor IX 抗体
(1 reference)-
- 抗原 See all Coagulation Factor IX (F9) 抗体
- Coagulation Factor IX (F9)
-
适用
- 人, 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Coagulation Factor IX antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 交叉反应
- 人, 小鼠, 大鼠
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human Coagulation factor IXa heavy chain
- 亚型
- IgG
- Top Product
- Discover our top product F9 Primary Antibody
-
anti-Coagulation Factor IX (F9) (AA 96-190) antibody
F9 适用: 人 WB, ELISA, IP, RNAi 宿主: 小鼠 Monoclonal 2C9 unconjugated
anti-Coagulation Factor IX (F9) (AA 29-192) antibodyF9 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) (AA 144-239) antibodyF9 适用: 人 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) antibodyF9 适用: 人, 小鼠, 大鼠 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) antibodyF9 适用: 人 ELISA, IHC, IHC (p), IEP 宿主: 绵羊 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) (C-Term) antibodyF9 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) antibodyF9 适用: 人 ELISA, IHC, IHC (p), IEP 宿主: 山羊 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) antibodyF9 适用: 人 ICC, IHC (p), IF 宿主: 兔 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) (AA 232-455) antibodyF9 适用: 人 WB, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Coagulation Factor IX (F9) (AA 412-461) antibodyF9 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
WB 1:300-5000
IHC-P 1:200-400
IF(IHC-P) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
-
: "Surface functionalization-specific binding of coagulation factors by zinc oxide nanoparticles delays coagulation time and reduces thrombin generation potential in vitro." in: PLoS ONE, Vol. 12, Issue 7, pp. e0181634, (2017) (PubMed).
-
: "Surface functionalization-specific binding of coagulation factors by zinc oxide nanoparticles delays coagulation time and reduces thrombin generation potential in vitro." in: PLoS ONE, Vol. 12, Issue 7, pp. e0181634, (2017) (PubMed).
-
- 抗原
- Coagulation Factor IX (F9)
- 别名
- Factor 9 (F9 产品)
- 背景
-
Synonyms: Christmas Disease, Christmas factor, Coagulant factor IX, Coagulation factor 9, Coagulation factor IX plasma thromboplastic component, Coagulation factor IX, Coagulation factor IXa heavy chain, F9, FA9_HUMAN, Factor 9, Factor IX Deficiency, Factor9, FactorIX, FIX, GLA domain, Haemophilia B, MGC129641, MGC129642, P19 antibody Plasma thromboplastic component, Plasma thromboplastin component, PTC, Truncated coagulation factor IX.
Background: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).
- 基因ID
- 2158
-
